evidio domingo-musibay
Allina Health
Minneapolis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Editors
Allina Health
Minneapolis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Tangdou Hospital, Fourth Military Medical University
Xian, China
Review Editor
Cancer Molecular Targets and Therapeutics
Yaroslav-the-Wise Novgorod State University
Veliky Novgorod, Russia
Review Editor
Cancer Molecular Targets and Therapeutics
Faculty of Medicine, Mansoura University
Mansoura, Egypt
Review Editor
Cancer Molecular Targets and Therapeutics
Hebrew University of Jerusalem
Jerusalem, Israel
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas Medical Branch at Galveston
Galveston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Florida
Gainesville, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Divisione di oncologia medica, Ospedale Santa Maria delle Grazie
Pozzuoli, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of Massachusetts Medical School
Worcester, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Institute of Biomedical and Genetic Engineering (IBGE)
Islamabad, Pakistan
Review Editor
Cancer Molecular Targets and Therapeutics
Faculty of Sciences and Technology, New University of Lisbon
Caparica, Portugal
Review Editor
Cancer Molecular Targets and Therapeutics
Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Centre for Tumor Biology, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
Virginia Commonwealth University
Richmond, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University Hospital rechts der Isar, Technical University of Munich
Munich, Germany
Review Editor
Cancer Molecular Targets and Therapeutics